N. Argento

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring

I. Hirsch, S. Edelman, N. Argento, 2018, Diabetes Care.

Flash forward, with caution

N. Argento, 2018, Diabetic medicine : a journal of the British Diabetic Association.

FLASH GLUCOSE MONITORING: A PATIENT'S AND CLINICIAN'S CAVEATS AND CONCERNS.

N. Argento, 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

GLYCEMIC EFFECTS OF SGLT-2 INHIBITOR CANAGLIFLOZIN IN TYPE 1 DIABETES PATIENTS USING THE DEXCOM G4 PLATINUM CGM.

N. Argento, Katherine Nakamura, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Hemoglobin A1C, mean glucose, and persistence of glycation ratios in insulin-treated diabetes.

N. Argento, Katherine Nakamura, R. Sala, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use.

G. Forlenza, L. Laffel, N. Argento, 2017, Diabetes technology & therapeutics.

All Children Deserve to Be Safe, Mothers Too: Evidence and Rationale Supporting CGM Use in Gestational Diabetes Within the Medicaid Population.

C. Parkin, N. Argento, C. Levy, 2023, Journal of diabetes science and technology.

Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes

N. Argento, Allyson S. Hughes, A. Mcauliffe-Fogarty, 2020, Journal of diabetes science and technology.

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring

I. Hirsch, S. Edelman, N. Argento, 2018, Diabetes Care.